Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis

被引：0
|
作者：
Falantes, J. [1 ]
Calderon, C. [1 ]
Marquez-Malaver, F. J. [1 ]
Aguilar, M. [2 ]
Martino, M. L. [1 ]
Gonzalez, J. [1 ]
Montero, M. I. [1 ]
Parody, R. [1 ]
Espigado, I. [1 ]
Perez-Simon, J. A. [1 ]
机构：
[1] Hosp Virgen Rocio, Hematol, Inst Biomed Sevilla IBIS, Seville, Spain
[2] Hosp Virgen Rocio, Infect Dis, Seville, Spain
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70043-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-021
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [41] Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)
    Sallman, David A.
    DeZern, Amy E.
    Garcia-Manero, Guillermo
    Steensma, David P.
    Roboz, Gail J.
    Sekeres, Mikkael A.
    Cluzeau, Thomas
    Sweet, Kendra L.
    McLemore, Amy F.
    McGraw, Kathy
    Puskas, John
    Zhang, Ling
    Yao, Jiqiang
    Mo, Qianxing
    Nardelli, Lisa
    Al Ali, Najla
    Padron, Eric
    Korbel, Greg
    Attar, Eyal C.
    Kantarjian, Hagop M.
    Lancet, Jeffrey E.
    Fenaux, Pierre
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2019, 134
  • [42] Nature of Clinical Response and Depth of Molecular Response in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Treated with Magrolimab with Azacitidine
    Johnson, Lisa
    Zhang, Yajia
    Li, Biao
    Aviles, Lisa
    Lal, Indu
    Ramsingh, Giri
    Daver, Naval
    Vyas, Paresh
    Sallman, David A.
    BLOOD, 2022, 140 : 6934 - 6935
  • [43] Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
    Kenealy, Melita
    Patton, Nigel
    Filshie, Robin
    Nicol, Andrew
    Ho, Shir-Jing
    Hertzberg, Mark
    Mills, Tony
    Prosser, Ian
    Link, Emma
    Cowan, Linda
    Zannino, Diana
    Seymour, John F.
    LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 298 - 307
  • [44] Phase 1 study of LP-108 as monotherapy and in combination with azacitidine in patients with relapsed or refractory myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML).
    Walker, Alison R.
    Bergua Burgues, Juan Miguel
    Montesinos, Pau
    Bixby, Dale
    Guastad Daver, Naval
    Konopleva, Marina
    Patrick Anthony, Stephen
    Tan, Fenlai
    Chen, Yi
    Chen, Yu
    Shen, Yue
    William Burke, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ault, Patricia S.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan H.
    Jabbour, Elias J.
    Cleeland, Charles S.
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [46] Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia
    Meers, S.
    Selleslag, D.
    Potier, H.
    Glasmacher, A.
    Mineur, P.
    Voelter, V.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 35 - 42
  • [47] CHROMOSOMAL STUDIES IN 24 PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIAS (AML) AND MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    HOFFMANN, R
    SUCIU, S
    KUSE, R
    HOSSFELD, DK
    BLUT, 1987, 55 (04): : 236 - 236
  • [48] Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    BLOOD, 2010, 116 (21) : 199 - 199
  • [49] 5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience
    Freyrie, Alessandra
    Reda, Gianluigi
    Vincenti, Daniele
    Sciume, Mariarita
    Binda, Francesca
    Guidotti, Francesca
    Cortelezzi, Agostino
    BLOOD, 2012, 120 (21)
  • [50] The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole
    Barreto, Jason N.
    Beach, Cassidy L.
    Wolf, Robert C.
    Merten, Julianna A.
    Tosh, Pritish K.
    Wilson, John W.
    Hogan, William J.
    Litzow, Mark R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (04) : 283 - 288
12345